Urinary Pathogens Research Articles

Therapeutic Efficacy and Molecular Docking Analysis of Plant Extracts Against Urinary Tract Infection Pathogens

Therapeutic Efficacy and Molecular Docking Analysis of Plant Extracts Against Urinary Tract Infection Pathogens

Enhancing antimicrobial management: A 5–year retrospective analysis of urinary pathogen susceptibility at a tertiary care centre from January 2018 to December 2022

Objective: The study aims to collect data on prevalence and antibiotic susceptibility patterns of uropathogens in a hospital in India, and to analyze any changes that have occurred over the past 5 years. Methods: This retrospective study was conducted over 5 years at Lady Hardinge Medical College & Associated Hospitals, New Delhi. Urine samples from patients who attended outpatient department or were admitted with diagnosis of urinary tract infection (UTI) were included in this study. Samples were cultured and tested to identify bacteria and determine antibiotic susceptibility using the Kirby-Bauer disc diffusion method. Results: A total of number of 151395 urine specimens were collected from January 2018 to December 2022. The prevalence of UTI was 7.5% (11372/151395) with the majority of patients being aged above 40 years (19.3%). The prevalence was higher in females (12.7%) as compared to males (3.2%). Escherichia (E.) coli was the predominant pathogen, accounting for 59.8% of cases, followed by Klebsiella spp. at 18.9%, and Enterococcus spp. at 8.3%. Gram-negative bacteria accounted for 89.5% of the isolates and exhibited good susceptibility to aminoglycosides and piperacillin-tazobactam, but showed resistance to fluoroquinolones. Methicillin-resistant Staphylococcus aureus (MRSA) was present in 35% of Staphylococcus (S.) aureus isolates with high susceptibility to glycopeptides and nitrofurantoin. Conclusions: The data suggest the need for careful selection of empirical therapy due to increasing resistance patterns. The stringent use of antimicrobial agents is pivotal to the control of antimicrobial resistance. Antibiotic susceptibility data contributes to tailoring the antibiotic stewardship programs to local needs.

Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study.

Urinary tract infection (UTI) is one of the most prevalent bacterial infectious diseases worldwide. However, the resistance of urinary pathogens to other UTI antibiotics such as trimethoprim and trimethoprim/sulphamethoxazole increased. Pivmecillinam is a prodrug of mecillinam, which is effective for the treatment of urinary tract infections. The purpose of this study was to assess the safety, and pharmacokinetics of pivmecillinam and mecillinam after single- and multiple-dose oral administration of pivmecillinam tablets in healthy Chinese subjects. The study also investigated the profile of urinary excretion of mecillinam, as well as the effect of food and gender on the pharmacokinetics of pivmecillinam and mecillinam. This study was a single-center, open-label phase I study carried out in three groups. In total, 34 subjects were included in the study: group 1-food effect study with pivmecillinam 200mg (n = 12); group 2-single- and multiple-dose study with pivmecillinam 400mg (n = 12); group 3-single dose study with pivmecillinam 600mg (n = 10). The plasma and urine concentrations of pivmecillinam and mecillinam were measured, and their pharmacokinetics were calculated. Treatment-emergent adverse events were evaluated and recorded in safety assessments for three groups. No severe adverse events were found in this study. After a single dose of pivmecillinam was taken orally, the maximum plasma concentration (Cmax) and the area under the concentration-time curve (AUC) of pivmecillinam increased in a dose-proportional manner, nor did mecillinam. Food had significant effects on Cmax and AUC0-t of pivmecillinam and Cmax of mecillinam. The mean cumulative percentage of urine excretion of mecillinam at 0 to 24h ranged from 35.5 to 44.0%. Urinary cumulative excretion is relative to the drug dose, but the diet and multiple-dose administration did not affect the urinary cumulative excretion rate. The safety and pharmacokinetics of pivmecillinam and mecillinam after single- (200/400/600mg) or multiple-dose (400mg) administration were demonstrated in healthy Chinese subjects. Food affected the pharmacokinetics of pivmecillinam and mecillinam.

Urinary tract infection pathogens diagnosed in Basra city hospitals

Background. Urinary tract infection (UTI) is the growth of pathological bacteria within the urinary tract, and is one of the most common types of bacterial infections worldwide. Bacterial resistance to antibiotics is a major public health concern. Antibiotic-resistant bacterial infections exacerbate the situation in developed, developing and underdeveloped countries. Objective. The aim of this research is to identify the frequency of different bacterial pathogens and their sensitivity to different types of antibiotics in patients suffering from UTI in Basra city hospitals. Method. This cross-sectional study included 505 samples positive for bacterial growth. It was conducted by data extraction from hospital laboratory records, where information was obtained about bacterial examination of urine samples taken from patients with urinary tract infection. The samples were cultured and antibiotic sensitivity was tested by laboratory workers, in order to determine the appropriate treatment for patients. Results and conclusions. The average age of patients was 43.5 years, of whom (60.4%) were females. The most common bacteria was Escherichia coli (40.6%). In antibiotic susceptibility testing process, gentamicin (5.7%), ciprofloxacin (4.7%), trimethoprim (4.7%), trimethoprim/sulfamethoxazole (4.1%), and cefepime (3.9%) were the most frequently used antibiotics, while cefotetan (0.06%), ampicillin-sulbactam (0.09%), mupirocin (0.2%), cefazolin (0.2%), fosfomycin and amoxicillin (0.2%) were the least used. The highest sensitivity shown by cultured bacteria was to linezolid (95.5%), ertapenem (91.7%), teicoplanin (79.4%), nitrofurantoin (75.2%) and amikacin (72.4%). The highest resistance shown by cultured bacteria was to cefazolin (100%), oxacillin (94.6%), fusidic acid (91.2%), ampicillin (90.4%), and amoxicillin (88.2%).

Clinico-Bacteriological Study and Antibiotic Resistance Pattern of Urinary Pathogens in Pediatric Patients in a Tertiary Care Center at Kanpur

Clinico-Bacteriological Study and Antibiotic Resistance Pattern of Urinary Pathogens in Pediatric Patients in a Tertiary Care Center at Kanpur

Frequency of Bacteria Causing Urinary Tract Infection and Their Antibiotic Resistance Among Children

Background: Childhood urinary tract infections (UTIs) are among the most prevalent diseases. In recent years, the overuse of common antibiotics has increased antibiotic resistance among urinary tract pathogens worldwide, with changes in the pattern of microbial resistance varying by geographical area and time. Objectives: This study aims to investigate the pattern of microbial resistance of UTI pathogens in pediatric patients. Methods: In this cross-sectional study, children aged < 13 years with UTI and positive urine cultures, who were admitted to Bahrami Hospital in Tehran, Iran, between 2015 and 2019, were evaluated. The pathogens' frequency, their antimicrobial resistance, and clinical and demographic information were extracted from the patients' files. Statistical relationships between clinical and demographic data and antibiotic resistance were analyzed using appropriate statistical tests. Results: The files of 202 patients were evaluated. The majority of patients were female (79.2%). UTI was more common among the 12 - 60 months age group (36.3%) in females and the 1 - 12 months age group (50%) in males. The most common UTI pathogen was Escherichia coli (85.1%). The lowest rates of microbial resistance were related to Meropenem (0% resistance), Gentamicin (9.2%), and Amikacin (10.8%). Conversely, the highest resistance rates were observed for Cotrimoxazole (74.6%), Ampicillin (74.5%), and Cephalothin (64.9%). Conclusions: UTI is more common in females aged 1 to 60 months. E. coli is the most common cause of UTI. Microbial resistance to antibiotics used for empirical treatment, such as ceftriaxone, is high and changes over time. It is recommended to use alternative antibiotics and avoid the inappropriate administration of antibiotics.

Pyuria, bacteriuria and empirical antibiotic selection in pregnant women

Aims: In pregnancy, early diagnosis and proper treatment of urinary tract infections are crucial in preventing maternal and fetal comorbidities. Therefore, pregnant women should be screened for asymptomatic bacteriuria. This study aimed to evaluate the relationship between pyuria and bacteriuria and the susceptibility of uropathogens, as well as to review the empiric drug options for pregnant women. Methods: The presence of pyuria and bacteriuria in urine samples obtained from the pregnant outpatient clinic between January 2023 and December 2023 at Kırıkkale University Faculty of Medicine Hospital’s Infectious Diseases and Clinical Microbiology Laboratory was investigated. Uropathogens were identified and typed using the BD Phoenix™ M50 automated system for bacterial identification and antibiotic susceptibility testing, and antibiotic susceptibility was interpreted according to the European Committee on Antimicrobial Susceptibility Testing criteria. Results: A total of 1457 urine samples were evaluated in this retrospective study. Uropathogens were detected in 235 patients, while 301 samples were considered contaminated. Uropathogens were found to be susceptible to amoxicillin-clavulanate, trimethoprim-sulfamethoxazole, nitrofurantoin, and fosfomycin, in that order, for use in pregnant women. High resistance rates to third-generation cephalosporins were observed. Conclusion: According to the results of this study, local resistance rates against urinary pathogens in pregnant women should be determined at specific intervals, and empirical antibiotic therapy should be planned based on these data.

PREVALENCE OF URINARY TRACT INFECTION AMONG OUT PATIENTS A JOS HOSPITAL PLATEAU STATE NIGERIA.

Infection of the urinary tract(called UTI) is caused by microbes thatinvade and inhabit the urinary system (urethra, bladder, ureters, andkidney). Because the urine is an excellent culture medium for the UTI pathogens,these pathogens ascend into the urinary system causing UTI varying from boils, cystitis, and prostitis which may even lead to sepsis if left untreated. This research was conducted to assess the preponderance of UTI among out-patients who attendedthe Plateau Specialist Hospital, Jos. We observed that of the 80 samples examined, 15 tested positive for UTI,suggesting a prevalence of 18.75%. According to age group, it was discovered that age group between 41 above has the highest prevalence of urinary tract infection with 12.5%. Based on gender, the female has the highest prevalence rate of 10(15.0%), though more in number than the males. the female were 60 out of 80 while the male were 20 in number. There was no positive sample obtained in children sample.It was discovered that Escherichia coli has the highest prevalence rate at 6(7.5%), followed by Staphylococcus aureus 4 (5.0%). The isolation of urinary tract pathogens from these patients though with a lower prevalence stresses the urgent need for public enlightenment campaigns by the appropriate authorities to educate the patients as well as the masses on the etiological agents, the possible risk factors, routes of transmission and health implication of urinary tract infection and ways of preventing the bacteria, as well as early diagnosis and treatment of infected ones.

Clinical, Microbiological Profile, and Treatment Outcomes of Carbapenem-Resistant Urinary Tract Infections in a Tertiary Care Hospital

Background Carbapenem-resistant urinary tract infections (CR-UTIs) are a major global health threat. Many factors contribute to the increasing incidence of CR-UTI. Owing to the limited availability of treatment options, CR-UTIs are highly challenging to treat. Materials and Methods This was a single-center, hospital-based, observational, retrospective cohort study. We investigated the treatment results, microbiological profiles, and clinical manifestations of CR-UTI at our institution between January 2017 and December 2021. All patients exhibiting clinical signs and symptoms of urinary tract infection (UTI) and a urine culture that showed growth of a single organism greater than 105 colony-forming units/ml were included. All patients were considered for a 1-year follow-up. Results From January 2017 to December 2022, 3016 (31%) CR-UTI episodes were noted. Approximately, 75% of CR-UTI episodes were caused by the most prevalent urinary pathogens, Escherichia coli and Klebsiella pneumoniae. Within 28 days, 308 patients (12.59%) died. Enterobacteriaceae treated for a minimum of 7–10 days showed a greater response to Aminoglycosides, Fosfomycin, Ceftizoxime, Colistin with Carbapenem, Tigecycline with Carbapenem, and Ceftazidime/avibactam. Within a year, 994 CR-UTI episodes were identified in patients who were available for follow-up; and 38% of these episodes were the result of relapse. Three-quarters of the remaining incidents were recurrent, accounting for a higher mortality rate (14.2%) within a year. Conclusion Despite effective antibiotic treatment, CR-UTIs are associated with early relapse and recurrence. Newer effective treatment and preventive strategies are required to address this pandemic.

Antimicrobial Activity of Hydrocotyle umbellata L. Assisted Iron Oxide Nanoparticles against Urinary Tract Infection Pathogens

Antimicrobial Activity of Hydrocotyle umbellata L. Assisted Iron Oxide Nanoparticles against Urinary Tract Infection Pathogens

Investigating Urinary Pathogens and Their Antibiotic Resistance: A Cross-Sectional Urine Culture Study.

Urinary tract infections (UTIs) are among the most prevalent infectious diseases. Females are more affected than males. The primary culprit is Escherichia coli. Multiple research investigations have documented widespread antimicrobial resistance in uropathogens, sparking global concerns, especially regarding the rise of multidrug resistance (MDR). This cross-sectional study was conducted from December 2023 to March 2024. A non-probability purposive sampling technique was employed to select participants, and informed consent was obtained from them. Data were extracted from the culture and sensitivity reports of these patients. The collected data were meticulously entered into IBM SPSS Statistics for Windows, Version 21 (IBM Corp.,Armonk, NY). The findings were then presented using a blend of percentages and numerical figures, offering a clear and concise representation of the data. Our study of 313 participants showed a higher prevalence of UTIs in females (219, 70%) compared to males (94, 30%). E. coli and Citrobacter were the predominant pathogens, with E. coli and Citrobacter more common in females, while Enterobacter and Staphylococcus were more prevalent in males. Antibiogram analysis revealed sensitivities to specific drugs like nitrofurantoin and meropenem, while resistance was observed against others, including polymyxin B and ampicillin. These findings stress the need for tailored UTI treatment approaches. In conclusion, our research highlights a concerning trend of escalating antibiotic resistance among Pakistani patients with UTIs. Tobramycin B, ticarcillin-clavulanic acid, ampicillin, and clotrimazole exhibited the highest resistance rates, while imipenem, meropenem, nitrofurantoin, sulfonamides, and tigecycline demonstrated notable sensitivity. These findings emphasize the urgent need for the exploration of alternative treatment options to combat rising resistance levels effectively.

Antibacterial activities of phytochemicals against multidrug-resistant urinary tract pathogens

Antibacterial activities of phytochemicals against multidrug-resistant urinary tract pathogens

Antimicrobial Susceptibility of Canine and Feline Urinary Tract Infection Pathogens Isolated from Animals with Clinical Signs in European Veterinary Practices during the Period 2013-2018.

Bacterial urinary tract infections (UTIs) occur frequently in companion animals and are often treated with antibiotics. However, antimicrobial resistance can severely hamper treatment success. Therefore, antimicrobial susceptibility monitoring is key. UTI isolates were obtained from dogs and cats in two collection periods (ComPath II: 2013-2014 and ComPath III: 2017-2018) as part of CEESA's ComPath programme. Susceptibility testing of the UTI isolates (2021 in total) was carried out at one central laboratory using agar and broth dilution methodology as recommended by the Clinical and Laboratory Standards Institute. Escherichia coli was the most frequently isolated bacterium in UTI in both dogs (46.9%, 43.1%) and cats (61.2%, 48.3%) across ComPath II and ComPath III, respectively. The percentage of resistance in E. coli was low (<10%) across both programmes in both dogs and cats except for trimethoprim-sulfamethoxazole (dogs ComPath III: 12.9%; cats ComPath II: 13.0%) and enrofloxacin (10.5%), marbofloxacin (11.4%), and doxycycline (98.8%) for dogs in ComPath III. Three (7.5%) of the 40 isolated S. aureus bacteria in total were MRSA and harboured mecA. The level of multidrug resistance (MDR) was generally low and ranged from 0.0% for feline coagulase-negative Staphylococcus spp. to 11.7% for canine Proteus spp., except for a peak of MDR observed in canine Klebsiella isolates from ComPath II (36.7%). Overall, antimicrobial resistance for most canine and feline UTI pathogens isolated during the ComPath II and ComPath III programmes was low (1-10%) to moderate (10-20%).

The effect of Marrubium vulgare L extracts against urinary tract bacteria pathogens infection in Alassaba'a hospital, of west Tripoli

Urinary tract infections (UTIs) are common infections that happen by many types of bacteria. Some of bacteria have resistance against several types of antibiotics. Many medicinal plants used as an alternative treatment around the world. Marrubium vulgare L has been reported to exhibit several biological properties. Thus, the aim of current study is estimating antimicrobial activities of M. vulgare against Escherichia coli, Klebsiella pneumoniae and Staphylococcus aureus, which caused urinary tract infections, isolated from infected patients. In the results, the growth of all tested bacteria was inhibited strongly by methanol extract at 1.0% (w/v) with inhibition zones 11.00, 11.00 and 15.50 mm against E. coli, k. pneumoniae and S. aureus respectively. Besides, Minimum Inhibitory Concentration (MIC) values were ranged between 0.625 to 1.25 mg/mL. While, Minimum Bactericidal Concentration (MBC) values were ranging between 1.25 to 2.5 mg/mL. On the other hand, hexane extract also was inhibited the growth of E. coli, k. pneumoniae and S. aureus with inhibition zones 10.00, 11.00 and 12.50 mm respectively. In addition, MIC values ranging 2.5 mg/mL, while MBC values of 5 mg/mL against all bacteria. In conclusion, the methanol extract of M. vulgare had a strongly effects on all bacteria compared to hexane extract, thus it can be developed as anti-bacterial agent.

Emerging trends in urinary tract infection pathogens: Insights from K. oxytoca and M. morganii in Indian settings

Urinary tract infections (UTIs) are a significant global health concern affecting millions annually. In India, UTIs linked to various bacterial pathogens, particularly and present a formidable challenge. This study aimed to evaluate the occurrence of these bacteria in urine samples obtained from UTI patients in Indian settings. Our investigation identified a notable proportion of UTIs associated with and highlighting the necessity for customized therapeutic approaches. Additionally, we conducted antibiotic susceptibility testing to guide appropriate antibiotic selection. Our findings revealed that 90% of isolates exhibiting additional resistance to Azithromycin (AZK). These results emphasize the importance of judicious antibiotic use and continuous monitoring of antibiotic resistance in UTI-causing pathogens in Indian healthcare settings. This study contributes to UTI management strategies and the development of tailored treatment modalities for the Indian population.

Multiplexing the Identification of Microorganisms via Tandem Mass Tag Labeling Augmented by Interference Removal through a Novel Modification of the Expectation Maximization Algorithm.

Having fast, accurate, and broad spectrum methods for the identification of microorganisms is of paramount importance to public health, research, and safety. Bottom-up mass spectrometer-based proteomics has emerged as an effective tool for the accurate identification of microorganisms from microbial isolates. However, one major hurdle that limits the deployment of this tool for routine clinical diagnosis, and other areas of research such as culturomics, is the instrument time required for the mass spectrometer to analyze a single sample, which can take ∼1 h per sample, when using mass spectrometers that are presently used in most institutes. To address this issue, in this study, we employed, for the first time, tandem mass tags (TMTs) in multiplex identifications of microorganisms from multiple TMT-labeled samples in one MS/MS experiment. A difficulty encountered when using TMT labeling is the presence of interference in the measured intensities of TMT reporter ions. To correct for interference, we employed in the proposed method a modified version of the expectation maximization (EM) algorithm that redistributes the signal from ion interference back to the correct TMT-labeled samples. We have evaluated the sensitivity and specificity of the proposed method using 94 MS/MS experiments (covering a broad range of protein concentration ratios across TMT-labeled channels and experimental parameters), containing a total of 1931 true positive TMT-labeled channels and 317 true negative TMT-labeled channels. The results of the evaluation show that the proposed method has an identification sensitivity of 93-97% and a specificity of 100% at the species level. Furthermore, as a proof of concept, using an in-house-generated data set composed of some of the most common urinary tract pathogens, we demonstrated that by using the proposed method the mass spectrometer time required per sample, using a 1 h LC-MS/MS run, can be reduced to 10 and 6 min when samples are labeled with TMT-6 and TMT-10, respectively. The proposed method can also be used along with Orbitrap mass spectrometers that have faster MS/MS acquisition rates, like the recently released Orbitrap Astral mass spectrometer, to further reduce the mass spectrometer time required per sample.

Antibacterial and antibiofilm activities of selenium nanoparticles-antibiotic conjugates against anti-multidrug-resistant bacteria

The crucial demand to overcome the issue of multidrug resistance is required to refine the performance of antibiotics. Such a process can be achieved by fastening them to compatible nanoparticles to obtain effective pharmaceuticals at a low concentration. Thus, selenium nanoparticles (Se NPs) are considered biocompatible agents that are applied to prevent infections resulting from bacterial resistance to multi-antibiotics. The current evaluated the effectiveness of Se NPs and their conjugates with antibiotics such as amikacin (AK), levofloxacin (LEV), and piperacillin (PIP) against Pseudomonas aeruginosa (P. aeruginosa). In addition, the study determined the antibacterial and antibiofilm properties of Se NPs and their conjugates with LEV against urinary tract pathogens such as Staphylococcus aureus (S. aureus), Enterococcus faecalis (E. faecalis), P. aeruginosa, and Escherichia coli (E. coli). The result of minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) for eight isolates of P. aeruginosa revealed that the conjugation of Se NPs with AK, LEV, and PIP resulted in a reduction in the concentration of antibiotic-conjugated Se NPs. The concentration was found to be about 10–20 times lower than that of bare antibiotics. The MIC of the Se NPs with LEV (i.e., Se NPs:LEV) for S. aureus, E. faecalis, P. aeruginosa, and E. coli was found to be 1.4:0.5, 0.7:0.25, 22:8, and 11:4 µg/mL, respectively. The results of the half-maximal inhibitory concentration (IC50) demonstrated that Se NPs:LEV conjugate have inhibited 50 % of the mature biofilms of S. aureus, E. faecalis, P. aeruginosa, and E. coli at a concentration of 27.5 ± 10.5, 18.8 ± 3.1, 40.6 ± 10.7, and 21.6 ± 3.3 µg/mL, respectively compared to the control. It has been suggested that the antibiotic-conjugated Se NPs have great potential for biomedical applications. The conjugation of Se NPs with AK, LEV, and PIP increases the antibacterial potency against resistant pathogens at a low concentration.

Prevalence and antimicrobial resistant &lt;i&gt;Escherichia coli&lt;/i&gt; and &lt;i&gt;Klebsiella&lt;/i&gt; sp among individuals with urinary tract infection from hospital and community settings in Ado-Ekiti, Nigeria

The antibiotic resistance of urinary pathogens has been varying over the period of years, in community and healthcare-associated infections. The study provided the current prevalence and antimicrobial-resistant Escherichia coli and Klebsiella sp among individuals with urinary tract infections from hospital and community settings in Ado-Ekiti, Nigeria. Midstream urine samples were collected and studied using standard microbiological techniques. Information for the factors associated with UTIs was obtained using questionnaires. An agar disc diffusion technique was used to test for antibiotic susceptibility. The chi-square test and Poisson regression was used to express associations among descriptive variables of UTI. The study revealed females are more susceptible to UTIs than males. Bacterial isolates showed a low prevalence of UTI with 122(8.5%). The age-wise distribution shows that the Incidence is more common in age bracket 51-60 and 21to 30 years. Gender and risk factors among the individuals had a significant relationship with UTIs. Overall, the bacterial strains showed the highest resistance to amoxicillin-clavulanate 43(91.5%) and most susceptible to imipenem 40(85.1%). The bacteria isolates also showed high multiple resistance with 0.6 MAR index. Appropriate diagnosis and management of UTI are aimed at treating the acute occurrence as well as preventing recurrences of this infection.

Effect of nano-silver coated catheter combined with comprehensive care on postoperative infection and rehabilitation in patients after coronary artery bypass grafting (CABG)

Coronary artery bypass grafting (CABG) is an effective treatment method for coronary atherosclerosis, aiming to improve patients’ quality of life and facilitate their return to normal activities after surgery. This study examines the effects of comprehensive nursing intervention and application of nano-silver coated catheter on postoperative infection and rehabilitation among patients who have undergone coronary artery bypass grafting. The study included 72 patients, randomly assigned into an intervention group and a control group, with 36 patients in each. The control group received standard care, while the intervention group received comprehensive care along with postoperative application of nano-silver coated catheter. The study compared various factors, including the Hamilton Anxiety Scale (HAMA) score, quality of life score, postoperative recovery, postoperative infection, satisfaction, and adverse reactions between the two groups. The intervention group exhibited better scores in HAMD, HAMA, PSQI and quality of survival score when compared to the control group. Moreover, the intervention group experienced an earlier time to first bowel movement and first defecation after surgery. The intervention group also demonstrated lower rates of urinary protein detection, pathogen detection, and serum inflammatory factor levels compared to the control group. Additionally, the overall incidence of complications in the control group was higher at 27.8% compared to 8.3% in the intervention group. Furthermore, the satisfaction level in the intervention group was significantly higher at 97.2%, in contrast to 83.3% in the control group. Overall, comprehensive care combined with the postoperative application of a nano-silver coated catheter can effectively address patients’ emotional needs and accelerate recovery. It also reduces the incidence of infection, ultimately enhancing the quality of life and satisfaction levels among patients. This study provides a good nursing plan for the postoperative recovery of CABG patients, which is conducive to promoting the speed of postoperative recovery and improving the quality of life of patients.

Risk factors of early infectious complications after ureterorenoscopy for stone disease: a prospective study.

To prospectively evaluate the rate and associated risk factors of early infectious complications after ureterorenoscopy for urolithiasis. After ethical committee approval, 400 therapeutic retrograde ureterorenoscopy procedures between August 3, 2020 and November 24, 2021 were included for analysis in a single-center study. Postoperative infection was defined as an afebrile urinary tract infection, fever (≥ 38°C) with pyuria (≥ 300WBC/μL) or proven urinary pathogen, and urosepsis. The primary outcome was the rate of infectious complications after ureterorenoscopy. Secondary outcomes were the perioperative factors that increased the risk of infectious complications within 30days of surgery using univariate and multivariate logistic regression analysis. Twenty-nine of four hundred (7.3%) patients developed an infectious complication within 30days after ureterorenoscopy. Ten (2.5%) patients developed an afebrile urinary tract infection, eight (2.0%) developed fever with pyuria, five (1.3%) febrile urinary tract infection, and six (1.5%) urosepsis. On univariate analysis, preoperative stent-type JFil® pigtail suture stent was significantly associated with the dependent variable (p < 0.001). On multivariate logistic regression analysis, older age (OR 1.035; 95% CI 1.006-1.070; p = 0.02) was found to be significantly associated with developing a postoperative infectious complication. A 7.3% rate of postoperative infectious complications and 1.5% urosepsis rate were observed after therapeutic ureterorenoscopy, without the need of intensive care admission. The only significant risk factors were preoperative stent type (JFil® pigtail suture stent) on univariate analysis, and older age on multivariate logistic regression analysis. Further multicentric prospective observational data are needed in this field.